Dihydronarwedine is a metabolite of Galanthamine, a selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer’s disease and disorders resulting from reduced neuronal metabolism.
Lycoraminon
expand collapse
